GGrantIndex
← Search

EPIGENETIC MODULATION OF IMMUNE-SUPPRESSED MESENCHYMAL TRIPLE-NEGATIVE BREAST CANCER

$1,703,689FY2021Defense Health AgencyDOD

Vanderbilt University Medical Center, Nashville TN

Investigators

View source on USAspending →
EPIGENETIC MODULATION OF IMMUNE-SUPPRESSED MESENCHYMAL TRIPLE-NEGATIVE BREAST CANCER · GrantIndex